Alivus Life Sciences Ltd.

The March 2022 quarter revenue stood at Rs. 5140.57 millions, up 10.04% as compared to Rs. 4671.63 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -5.53% to Rs. 988.97  millions from Rs. 1046.84 millions.The company reported a degrowth in operating Profit to 1473.06 millions from 1702.26 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202203	202103	% Var	202203	202103	% Var	202203	202103	% Var
Sales	5140.57	4671.63	10.04	21232.14	18851.65	12.63	21232.14	18851.65	12.63
Other Income	50.95	3.41	1394.13	147.04	8.11	1713.07	147.04	8.11	1713.07
PBIDT	1473.06	1702.26	-13.46	6307.64	5918.85	6.57	6307.64	5918.85	6.57
Interest	1.25	211.78	-99.41	279.62	875.47	-68.06	279.62	875.47	-68.06
PBDT	1471.81	1490.48	-1.25	6028.02	5043.38	19.52	6028.02	5043.38	19.52
Depreciation	95.54	84.26	13.39	378.77	333.94	13.42	378.77	333.94	13.42
PBT	1376.27	1406.22	-2.13	5649.25	4709.44	19.96	5649.25	4709.44	19.96
TAX	387.30	359.38	7.77	1462.01	1193.63	22.48	1462.01	1193.63	22.48
Deferred Tax	18.25	11.94	52.85	85.74	66.17	29.58	85.74	66.17	29.58
PAT	988.97	1046.84	-5.53	4187.24	3515.81	19.10	4187.24	3515.81	19.10
Equity	245.05	19.60	1150.26	245.05	19.60	1150.26	245.05	19.60	1150.26
PBIDTM(%)	28.66	36.44	-21.36	29.71	31.40	-5.38	29.71	31.40	-5.38